Combigan 0.2 % / 0.5 % Ophthalmic Solution

RxCUI
861637
RxNorm name
Combigan 0.2 % / 0.5 % Ophthalmic Solution
Display name
Combigan 0.2 % / 0.5 % Ophthalmic Solution
Full name
Combigan 0.2 % / 0.5 % Ophthalmic Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
COMBIGANBRIMONIDINE TARTRATE, TIMOLOL MALEATEAllergan, Inc.feaf1480-a4b8-4486-992a-96be3a5962432026-03-17Warnings, Adverse reactionsExact identifier
rxcui: 861637

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
feaf1480-a4b8-4486-992a-96be3a596243brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Combigan]SBD22These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 200720260317
feaf1480-a4b8-4486-992a-96be3a596243Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic SolutionSY22These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 200720260317
feaf1480-a4b8-4486-992a-96be3a596243Combigan 0.2 % / 0.5 % Ophthalmic SolutionPSN22These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 200720260317
8c641b6c-3335-4ec3-89b9-2d97a8901062Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic SolutionSY1These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 200720110415
8c641b6c-3335-4ec3-89b9-2d97a8901062brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Combigan]SBD1These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 200720110415
8c641b6c-3335-4ec3-89b9-2d97a8901062Combigan 0.2 % / 0.5 % Ophthalmic SolutionPSN1These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 200720110415